Xencor | XNCR - Market Capitalization

Stock Price
12.10
Daily Change
0.29 2.46%
Monthly
-7.07%
Yearly
-15.86%
Q1 Forecast
11.06

Xencor reported $721.8M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
Arrowhead Research USD 8.04B 973M Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Cytokinetics USD 8.27B 504M Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
MacroGenics USD 114M 8M Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Xencor USD 837M 278M Sep/2025